RBC Capital analyst Gregory Renza maintained a Hold rating on Fulcrum Therapeutics (FULC – Research Report) yesterday and set a price ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...

Fintel reports that on November 13, 2024, RBC Capital initiated coverage of Jumia Technologies AG - Depositary Receipt () (NYSE:JMIA) with a Sector Perform recommendation. Analyst Price Forecast ...

Fintel reports that on November 7, 2024, RBC Capital downgraded their outlook for Avid Bioservices (NasdaqCM:CDMO) from ...

A Donald Trump administration is poised to pull back on regulation in the U.S. banking industry, which is likely to create ...

Investing.com - Microsoft's first-quarter results and its current-quarter guidance have left many disappointed investors in ...

today announced participation including a fireside chat at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications (TIMT) Conference on Wednesday November 20, 2024 at 9: ...

RBC Capital Markets believes the U.S. election could serve as a key clearing moment for stocks, with positive effects on the ...

As of October 22, 2024, the average one-year price target for Cytokinetics is $84.06/share. The forecasts range from a low of $60.60 to a high of $126.00. The average price target represents an ...

TEMPE, Ariz., Nov. 6, 2024 /PRNewswire/ -- GoDaddy Inc. (NYSE: GDDY) Chief Financial Officer Mark McCaffrey will present at the 2024 RBC Capital Markets Global Technology, Internet, Media and ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

TipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including IBM and Ares Capital.